The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Open accessAbstract
The incidence of melanoma is increasing worldwide, and the prognosis for patients with high-risk or advanced metastatic melanoma remains poor despite advances in the field. Standard treatment for patients with thick (≥2.0 mm) primary melanoma with or without regional metastases to lymph nodes is surgery followed by adjuvant therapy or clinical trial enrollment. Adjuvant therapy with interferon-α and cancer vaccines is discussed in detail. Patients who progress to stage IV metastatic melanoma have a median survival of ≤1 year. Standard treatment with chemotherapy yields low response rates, of which few are durable. Cytokine therapy with IL-2 achieves durable benefits in a greater fraction, but it is accompanied by severe toxicities that require the patient to be hospitalized for support during treatment. A systematic literature review of treatments for advanced, metastatic disease was conducted to present the success of current treatments and the promise of those still in clinical development that may yield incremental improvements in the treatment of advanced, metastatic melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Self-citationKirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Self-citationAtkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
Attia, P., Phan, G. Q., Maker, A. V., Robinson, M. R., Quezado, M. M., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.205 · Cited by 1,012
Kirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., & Blum, R. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2444 · Cited by 912
Self-citationKirkwood, J. M., Ibrahim, J. G., Sosman, J. A., Sondak, V. K., Agarwala, S. S., Ernstoff, M. S., & Rao, U. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2370 · Cited by 898
Self-citationDudley, M. E., Wunderlich, J. R., Shelton, T. E., Even, J., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200307000-00005 · Cited by 701
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis
Eisen, T., Ahmad, T., Flaherty, K. T., Gore, M., Kaye, S., Marais, R., Gibbens, I., Hackett, S., James, M., Schuchter, L. M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603291 · Cited by 644
Eggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61033-8 · Cited by 640
Self-citationBedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0483 · Cited by 600
Self-citationRibas, A., Camacho, L. H., Lopez-Berestein, G., Pavlov, D., Bulanhagui, C. A., Millham, R., Comin-Anduix, B., Reuben, J. M., Seja, E., Parker, C. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.109 · Cited by 591
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma
Lens, M. B., & Dawes, M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05708.x · Cited by 567
Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon
Gogas, H., Ioannovich, J., Dafni, U., Stavropoulou-Giokas, C., Frangia, K., Tsoutsos, D., Panagiotou, P., Polyzos, A., Papadopoulos, O., Stratigos, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053007 · Cited by 566
Self-citationHauschild, A., Agarwala, S. S., Trefzer, U., Hogg, D., Robert, C., Hersey, P., Eggermont, A., Grabbe, S., Gonzalez, R., Gille, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7636 · Cited by 548
Self-citationMocellin, S., Pasquali, S., Rossi, C. R., & Nitti, D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq009 · Cited by 527
Prognostic significance of autoimmunity during treatment of melanoma with interferon
Krauze, M. T., Tarhini, A., Gogas, H., & Kirkwood, J. M. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0247-y · Cited by 507
Self-citationExcision Margins in High-Risk Malignant Melanoma
Thomas, J. M., Newton‐Bishop, J., A’Hern, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030681 · Cited by 504
Maker, A. V., Phan, G. Q., Attia, P., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., Haworth, L. R., Levy, C., et al. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.536 · Cited by 492
Avril, M. F., Aamdal, S., Grob, J. J., Hauschild, A., Mohr, P., Bonerandi, J. J., Weichenthal, M., Neuber, K., Bieber, T., Gilde, K., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.165 · Cited by 486
Self-citationThe Diagnosis and Treatment of Cough
Irwin, R. S., & Madison, J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432308 · Cited by 485
Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Bröcker, E.-B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj138 · Cited by 467
Satyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Volpe, P., Weber, B. L., Belle, P. A. V., Elder, D. E., & Herlyn, M. (2003) · PubMed · Cited by 445
Grob, J. J., Dreno, B., de la Salmoniere, P., Delaunay, M., Cupissol, D., Guillot, B., Souteyrand, P., Sassolas, B., Cesarini, J.-P., Lionnet, S., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12445-x · Cited by 433
Davies, B. R., Logie, A., McKay, J. S., Martin, P., Steele, S., Jenkins, R., Cockerill, M., Cartlidge, S., & Smith, P. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0231 · Cited by 387
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
Eggermont, A. M. M., & Kirkwood, J. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.030 · Cited by 383
Self-citationWheatley, K., Ives, N., Hancock, B., Gore, M., Eggermont, A., & Suciu, S. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00074-4 · Cited by 341
Eigentler, T. K., Caroli, U. M., Radny, P., & Garbe, C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01280-4 · Cited by 324
Self-citationAtkins, M. B., Hsu, J., Lee, S., Cohen, G. I., Flaherty, L. E., Sosman, J. A., Sondak, V. K., & Kirkwood, J. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5448 · Cited by 320
Self-citationDiagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Spatz, A., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.032 · Cited by 317
Self-citationEggermont, A. M., Suciu, S., MacKie, R., Ruka, W., Testori, A., Kruit, W., Punt, C. J., Delauney, M., Sales, F., Groenewegen, G., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67482-x · Cited by 311
Self-citationIves, N. J., Stowe, R. L., Lorigan, P., & Wheatley, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0253 · Cited by 284
Kefford, R., Arkenau, H., Brown, M. P., Millward, M., Infante, J. R., Long, G. V., Ouellet, D., Curtis, M., Lebowitz, P. F., & Falchook, G. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.8503 · Cited by 275
Cascinelli, N., Belli, F., MacKie, R. M., Santinami, M., Bufalino, R., & Morabito, A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06068-8 · Cited by 250
McDermott, D. F., Sosman, J. A., Gonzalez, R., Hodi, F. S., Linette, G. P., Richards, J., Jakub, J. W., Beeram, M., Tarantolo, S., Agarwala, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8288 · Cited by 250
Self-citationMoschos, S. J., Edington, H. D., Land, S. R., Rao, U. N., Jukic, D., Shipe-Spotloe, J., & Kirkwood, J. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2498 · Cited by 242
Self-citationKirkwood, J. M., Lorigan, P., Hersey, P., Hauschild, A., Robert, C., McDermott, D., Marshall, M. A., Gomez-Navarro, J., Liang, J. Q., & Bulanhagui, C. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2033 · Cited by 241
Self-citationFlaherty, K., Puzanov, I., Sosman, J., Kim, K., Ribas, A., McArthur, G., Lee, R. J., Grippo, J. F., Nolop, K., & Chapman, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.9000 · Cited by 229
Diagnosis and treatment of cutaneous melanoma: state of the art 2006*
Garbe, C., & Eigentler, T. K. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e328042bb36 · Cited by 223
Self-citationPatel, P. M., Suciu, S., Mortier, L., Kruit, W. H., Robert, C., Schadendorf, D., Trefzer, U., Punt, C. J. A., Dummer, R., Davidson, N., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.030 · Cited by 211
Self-citationO'Day, S., Gonzalez, R., Lawson, D., Weber, R., Hutchins, L., Anderson, C., Haddad, J., Kong, S., Williams, A., & Jacobson, E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1579 · Cited by 208
Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b
Yurkovetsky, Z. R., Kirkwood, J. M., Edington, H. D., Marrangoni, A. M., Velikokhatnaya, L., Winans, M. T., Gorelik, E., & Lokshin, A. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1805 · Cited by 207
Self-citationInterleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.
Parkinson, D. R., Abrams, J. S., Wiernik, P. H., Rayner, A. A., Margolin, K. A., Van Echo, D. A., Sznol, M., Dutcher, J. P., Aronson, F. R., & Doroshow, J. H. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.10.1650 · Cited by 198
Morton, D. L., Mozzillo, N., Thompson, J. F., Kelley, M. C., Faries, M., Wagner, J., Schneebaum, S., Schuchter, L., Gammon, G., & Elashoff, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8508 · Cited by 177
Keilholz, U., Punt, C. J. A., Gore, M., Kruit, W., Patel, P., Lienard, D., Thomas, J., Proebstle, T. M., Schmittel, A., Schadendorf, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.202 · Cited by 165
Self-citationRibas, A., Hanson, D. C., Noe, D. A., Millham, R., Guyot, D. J., Bernstein, S. H., Canniff, P. C., Sharma, A., & Gomez-Navarro, J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-7-873 · Cited by 161
Chemotherapy and Targeted Therapy Combinations in Advanced Melanoma
Flaherty, K. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2505 · Cited by 159
Ribas, A., Hauschild, A., Kefford, R. F., Punt, C. J. A., Haanen, J. B. A. G., Mármol, M., Garbe, C., Gómez-Navarro, J., Pavlov, D., & Marshall, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.lba9011 · Cited by 155
Self-citationWheatley, K., Ives, N. J., Eggermont, A. M. M., Kirkwood, J. M., Cascinelli, N., Markovic, S. N., Hancock, B. W., Lee, S., & Suciu, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8526 · Cited by 154
Self-citationCytokine-Based Therapy and Biochemotherapy for Advanced Melanoma
Atkins, M. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2503 · Cited by 149
Coit, D. G., Andtbacka, R. H. I., Bichakjian, C. K., Dilawari, R. A., DiMaio, D. J., Guild, V., Halpern, A. C., Hodi, F. S., Kashani–Sabet, M., Lange, J. R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0020 · Cited by 149
Kirkwood, J. M., Lee, S., Moschos, S. J., Albertini, M. R., Michalak, J. C., Sander, C., Whiteside, T. L., Butterfield, L. H., & Weiner, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1231 · Cited by 138
Self-citationGarbe, C., Radny, P., Linse, R., Dummer, R., Gutzmer, R., Ulrich, J., Stadler, R., Weichenthal, M., Eigentler, T., Ellwanger, U., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn001 · Cited by 138
Self-citationDummer, R., Robert, C., Chapman, P. B., Sosman, J. A., Middleton, M. R., Bastholt, L., Kemsley, K., Cantarini, M., Morris, C., & Kirkwood, J. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.9033 · Cited by 132
Self-citationPectasides, D. G., Dafni, U. G., Bafaloukos, D. I., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3121 · Cited by 122
Besser, M. J., Shapira‐Frommer, R., Treves, A. J., Zippel, D. B., Itzhaki, O., Schallmach, E., Kubi, A., Shalmon, B., Hardan, I., Catane, R., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31819c8bda · Cited by 121
Safety and efficacy results from the first-in-human study of the oral MEK 1/2 inhibitor GSK1120212.
Infante, J. R., Fecher, L. A., Nallapareddy, S., Gordon, M. S., Flaherty, K. T., Cox, D. S., DeMarini, D. J., Morris, S. R., Burris, H. A., & Messersmith, W. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2503 · Cited by 121
Eggermont, A. M. M., Suciu, S., Rutkowski, P. L., Marsden, J. R., Santinami, M., Corrie, P. G., Aamdal, S., Ascierto, P. A., Patel, P. M., Kruit, W. H. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.9303 · Cited by 118
Wallen, H. D., Thompson, J. A., Reilly, J. Z., Rodmyre, R. M., Cao, J., & Yee, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004749 · Cited by 116
Bajetta, E., Vecchio, M. D., Nova, P., Fusi, A., Daponte, A., Sertoli, M. R., Queirolo, P., Taveggia, P., Bernengo, M. G., Legha, S. S., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl007 · Cited by 112
Am, E., Suciu, S., Santinami, M., Testori, A., Kruit, W. H. J., Marsden, J. R., Punt, C. J. A., Salès, F., Gore, M. E., MacKie, R., et al. (2008) · Research Explorer (The University of Manchester) · Cited by 111
Self-citationDanson, S. J., Lorigan, P. C., Arance, A. M., Clamp, A. R., Ranson, M., Hodgetts, J., Lomax, L., Ashcroft, L., Thatcher, N., & Middleton, M. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.039 · Cited by 106
Systemic chemotherapy in the treatment of malignant melanoma
Lens, M. B., & Eisen, T. G. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.12.2205 · Cited by 98
Randomized Adjuvant Therapy Trials in Melanoma: Surgical and Systemic
Eggermont, A. M. M., & Gore, M. E. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.09.003 · Cited by 87
Schwartzentruber, D. J., Lawson, D. J., Richards, J. M., Conry, R. M., Miller, D. M., Triesman, J., Gailani, F., Riley, L., Vena, D. A., & Hwu, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.cra9011 · Cited by 83
Kim, C. J., Dessureault, S., Gabrilovich, D., Reintgen, D. S., & Slingluff, C. L. (2002) · Cancer Control · doi:10.1177/107327480200900104 · Cited by 69
Adjuvant therapy of malignant melanoma
Molife, R., & Hancock, B. W. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00014-8 · Cited by 66
Reichle, A., VOGT, T. M., Coras, B., et al. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f1d2c8 · Cited by 57
Lewis, K. D., Robinson, W. A., McCarter, M. D., Pearlman, N. W., O'Day, S. J., Anderson, C., AMATRUDA, T. T., Barón, A. E., Zeng, C. X., Becker, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5344 · Cited by 54
Schwartzentruber, D. J., Lawson, D. J., Richards, J., Conry, R. M., Miller, D., Triesman, J., Gailani, F., Riley, L. B., Vena, D. A., & Hwu, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.18_suppl.cra9011 · Cited by 51
Koike, N., Pilon‐Thomas, S., & Mulé, J. J. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816cabbb · Cited by 47
O'Day, S. J., Atkins, M. B., Boasberg, P. D., Wang, H.-J., Thompson, J. A., Anderson, C. M., Gonzalez, R. C., Lutzky, J., AMATRUDA, T. T., Hersh, E. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3075 · Cited by 47
Kinetics of response to ipilimumab (MDX-010) in patients with stage III/IV melanoma
Hamid, O., Urba, W. J., Yellin, M. J., Nichol, G., Weber, J. S., Hersh, E. M., Tchekmedyian, S., Hodi, F. S., Weber, R. W., & O'Day, S. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8525 · Cited by 41
Weber, J. S., Hersh, E. M., Yellin, M. J., Nichol, G., Urba, W. J., Powderly, J. D., & O'Day, S. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8523 · Cited by 37
O'Day, S. J., Ibrahim, R. A., DePril, V., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.9021 · Cited by 35
Bruton, J., & Koeller, J. M. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb04156.x · Cited by 33
Vuoristo, M., Hahka‐Kemppinen, M., Parvinen, L.-M., Pyrhönen, S. O., Sepp, H., Korpela, M., & Kellokumpu‐Lehtinen, P. (2005) · Melanoma Research · doi:10.1097/00008390-200508000-00010 · Cited by 33
Kirkwood, J. M., Gonzalez, R. C., Reintgen, D. S., Clingan, P. R., McWilliams, R. R., de Alwis, D. P., Zimmermann, A. H., Brown, M. P., Ilaria, R. L., & Millward, M. J. (2011) · Cancer · doi:10.1002/cncr.26068 · Cited by 31
Self-citationShah, G., & Chapman, P. B. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e318074dfd4 · Cited by 27
Gómez-Navarro, J., Antonia, S. J., Sosman, J. A., Kirkwood, J. M., Redman, B. G., Gajewski, T. F., Pavlov, D., Bulanhagui, C. A., Ribas, A., & Camacho, L. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8524 · Cited by 19
Self-citationPunt, C. J. A., Suciu, S., Gore, M. A., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.012 · Cited by 18
Kirkwood, J. M., González, R., Reintgen, D. S., Clingan, P., McWilliams, R. R., Ilaria, R. L., de Alwis, D. P., Zimmermann, A., Brown, M. P., & Millward, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.8541 · Cited by 6
Self-citation
Cited by
Schadendorf, D., Hodi, F. S., Robert, C., Weber, J. S., Margolin, K., Hamid, O., Patt, D., Chen, T.-T., Berman, D. M., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2736 · Cited by 2,141
Hodi, F. S., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Cowey, C. L., Lao, C. D., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30700-9 · Cited by 1,399
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02229 · Cited by 1,117
Hodi, F. S., Chesney, J., Pavlick, A. C., Robert, C., Grossmann, K. F., McDermott, D. F., Linette, G. P., Meyer, N., Giguere, J. K., Agarwala, S. S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30366-7 · Cited by 968
Cross talk between mitochondria and NADPH oxidases
Dikalov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.033 · Cited by 783
Metadata
- Authors
- Garbe, C., Eigentler, T. K., Keilholz, U., Hauschild, A., & Kirkwood, J. M.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 5-24
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2155104279
- Cited by
- 582
- References
- 84
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.